George Farmer
Stock Analyst at Scotiabank
(2.62)
# 2,442
Out of 5,182 analysts
70
Total ratings
50%
Success rate
3.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Maintains: Sector Outperform | $30 → $10 | $2.05 | +387.80% | 4 | Aug 6, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $93 → $133 | $115.00 | +15.65% | 4 | Jul 31, 2025 | |
| INMB INmune Bio | Downgrades: Sector Underperform | $23 → $0.6 | $1.49 | -59.73% | 3 | Jul 1, 2025 | |
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $24.92 | +88.60% | 1 | Jun 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $23.78 | -28.51% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $5.30 | +126.42% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $1.94 | +363.92% | 4 | Apr 10, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $15.87 | +158.35% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $33.82 | +53.76% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $54.88 | +45.77% | 8 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $244 → $224 | $183.34 | +22.18% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $35.53 | +187.08% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $9.78 | +2.25% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $834.45 | -14.31% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $7.05 | +226.24% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $0.78 | +2,452.97% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $25.07 | +203.15% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $3.95 | +229.11% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $54.59 | +99.67% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $96.92 | -10.24% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $2.99 | +1,003.68% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.96 | +4,088.48% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $43.61 | -38.09% | 3 | May 6, 2020 |
Biomea Fusion
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $30 → $10
Current: $2.05
Upside: +387.80%
Arcellx
Jul 31, 2025
Maintains: Sector Outperform
Price Target: $93 → $133
Current: $115.00
Upside: +15.65%
INmune Bio
Jul 1, 2025
Downgrades: Sector Underperform
Price Target: $23 → $0.6
Current: $1.49
Upside: -59.73%
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $24.92
Upside: +88.60%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $23.78
Upside: -28.51%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $5.30
Upside: +126.42%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $1.94
Upside: +363.92%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $15.87
Upside: +158.35%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $33.82
Upside: +53.76%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $54.88
Upside: +45.77%
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $183.34
Upside: +22.18%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $35.53
Upside: +187.08%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $9.78
Upside: +2.25%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $834.45
Upside: -14.31%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $7.05
Upside: +226.24%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $0.78
Upside: +2,452.97%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $25.07
Upside: +203.15%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $3.95
Upside: +229.11%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $54.59
Upside: +99.67%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $96.92
Upside: -10.24%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $2.99
Upside: +1,003.68%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.96
Upside: +4,088.48%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $43.61
Upside: -38.09%